File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Liver involvement in early autosomal-dominant polycystic kidney disease

TitleLiver involvement in early autosomal-dominant polycystic kidney disease
Authors
KeywordsCKD
HALT-PKD-A
Hepatic cyst
MRI analysis
Issue Date2015
Citation
Clinical Gastroenterology and Hepatology, 2015, v. 13, n. 1, p. 155-164.e6 How to Cite?
AbstractBackground & Aims: Polycystic liver disease (PLD), the most common extrarenal manifestation of autosomal-dominant polycystic kidney disease (ADPKD), has become more prevalent as a result of increased life expectancy, improved renal survival, reduced cardiovascular mortality, and renal replacement therapy. No studies have fully characterized PLD in large cohorts. We investigated whether liver and cyst volumes are associated with volume of the hepatic parenchyma, results from liver laboratory tests, and patient-reported outcomes. Methods: We performed a cross-sectional analysis of baseline liver volumes, measured by magnetic resonance imaging, and their association with demographics, results from liver laboratory and other tests, and quality of life. The data were collected from a randomized, placebo-controlled trial underway at 7 tertiary-care medical centers to determine whether the combination of an angiotensin I-converting enzyme inhibitor and angiotensin II-receptor blocker was superior to the inhibitor alone, and whether low blood pressure (<110/75 mm Hg) was superior to standard blood pressure (120-130/70-80 mm Hg), in delaying renal cystic progression in 558 patients with ADPKD, stages 1 and 2 chronic kidney disease, and hypertension (age, 15-49 y). Results: We found hepatomegaly to be common among patients with ADPKD. Cysts and parenchyma contributed to hepatomegaly. Cysts were more common and liver and cyst volumes were greater in women, increasing with age. Patients with advanced disease had a relative loss of liver parenchyma. We observed small abnormalities in results from liver laboratory tests, and that splenomegaly and hypersplenism were associated with PLD severity. Higher liver volumes were associated with a lower quality of life. Conclusions: Hepatomegaly is common even in early stage ADPKD and is not accounted for by cysts alone. Parenchymal volumes were larger, compared with liver volumes of patients without ADPKD or with those predicted by standardized equations, even among patients without cysts. The severity of PLD was associated with altered biochemical and hematologic features, as well as quality of life. ClinicalTrials.gov identifier: NCT00283686.
Persistent Identifierhttp://hdl.handle.net/10722/316096
ISSN
2023 Impact Factor: 11.6
2023 SCImago Journal Rankings: 3.091
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorHogan, Marie C.-
dc.contributor.authorAbebe, Kaleab-
dc.contributor.authorTorres, Vicente E.-
dc.contributor.authorChapman, Arlene B.-
dc.contributor.authorBae, Kyongtae T.-
dc.contributor.authorTao, Cheng-
dc.contributor.authorSun, Hongliang-
dc.contributor.authorPerrone, Ronald D.-
dc.contributor.authorSteinman, Theodore I.-
dc.contributor.authorBraun, William-
dc.contributor.authorWinklhofer, Franz T.-
dc.contributor.authorMiskulin, Dana C.-
dc.contributor.authorRahbari-Oskoui, Frederic-
dc.contributor.authorBrosnahan, Godela-
dc.contributor.authorMasoumi, Amirali-
dc.contributor.authorKarpov, Irina O.-
dc.contributor.authorSpillane, Susan-
dc.contributor.authorFlessner, Michael-
dc.contributor.authorMoore, Charity G.-
dc.contributor.authorSchrier, Robert W.-
dc.date.accessioned2022-08-24T15:49:14Z-
dc.date.available2022-08-24T15:49:14Z-
dc.date.issued2015-
dc.identifier.citationClinical Gastroenterology and Hepatology, 2015, v. 13, n. 1, p. 155-164.e6-
dc.identifier.issn1542-3565-
dc.identifier.urihttp://hdl.handle.net/10722/316096-
dc.description.abstractBackground & Aims: Polycystic liver disease (PLD), the most common extrarenal manifestation of autosomal-dominant polycystic kidney disease (ADPKD), has become more prevalent as a result of increased life expectancy, improved renal survival, reduced cardiovascular mortality, and renal replacement therapy. No studies have fully characterized PLD in large cohorts. We investigated whether liver and cyst volumes are associated with volume of the hepatic parenchyma, results from liver laboratory tests, and patient-reported outcomes. Methods: We performed a cross-sectional analysis of baseline liver volumes, measured by magnetic resonance imaging, and their association with demographics, results from liver laboratory and other tests, and quality of life. The data were collected from a randomized, placebo-controlled trial underway at 7 tertiary-care medical centers to determine whether the combination of an angiotensin I-converting enzyme inhibitor and angiotensin II-receptor blocker was superior to the inhibitor alone, and whether low blood pressure (<110/75 mm Hg) was superior to standard blood pressure (120-130/70-80 mm Hg), in delaying renal cystic progression in 558 patients with ADPKD, stages 1 and 2 chronic kidney disease, and hypertension (age, 15-49 y). Results: We found hepatomegaly to be common among patients with ADPKD. Cysts and parenchyma contributed to hepatomegaly. Cysts were more common and liver and cyst volumes were greater in women, increasing with age. Patients with advanced disease had a relative loss of liver parenchyma. We observed small abnormalities in results from liver laboratory tests, and that splenomegaly and hypersplenism were associated with PLD severity. Higher liver volumes were associated with a lower quality of life. Conclusions: Hepatomegaly is common even in early stage ADPKD and is not accounted for by cysts alone. Parenchymal volumes were larger, compared with liver volumes of patients without ADPKD or with those predicted by standardized equations, even among patients without cysts. The severity of PLD was associated with altered biochemical and hematologic features, as well as quality of life. ClinicalTrials.gov identifier: NCT00283686.-
dc.languageeng-
dc.relation.ispartofClinical Gastroenterology and Hepatology-
dc.subjectCKD-
dc.subjectHALT-PKD-A-
dc.subjectHepatic cyst-
dc.subjectMRI analysis-
dc.titleLiver involvement in early autosomal-dominant polycystic kidney disease-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.cgh.2014.07.051-
dc.identifier.pmid25111236-
dc.identifier.scopuseid_2-s2.0-84916900344-
dc.identifier.volume13-
dc.identifier.issue1-
dc.identifier.spage155-
dc.identifier.epage164.e6-
dc.identifier.eissn1542-7714-
dc.identifier.isiWOS:000348040500027-
dc.identifier.f1000718524991-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats